Skip to content

Novavax NVAX Income Tax

Income Tax at other companies

Moderna logo
ModernaMRNA
$9M+28.6%
Merck & Co. logo
Merck & Co.MRK
$709M-13.3%
ALN
Alnylam PharmaceuticalsALNY
$15.66M-1.4%
Gilead Sciences logo
Gilead SciencesGILD
$559M+67.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$64K+23.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$9K+104%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's income tax?
Novavax (NVAX) reported income tax of $985K in Q1 2026.
How has Novavax's income tax changed year-over-year?
Novavax's income tax decreased by 17.9% year-over-year, from $1.2M to $985K.
What is the long-term trend for Novavax's income tax?
Over 3 years (2021 to 2025), Novavax's income tax has grown at a -60.0% compound annual growth rate (CAGR), from $29.22M to $1.87M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.